pathology_id stringlengths 19 19 | country stringclasses 7
values | year int64 2.02k 2.03k | facility_type stringclasses 3
values | cancer_type stringclasses 10
values | icd_o_morphology_code stringclasses 9
values | morphology_description stringclasses 9
values | grade stringclasses 4
values | lymphovascular_invasion stringclasses 3
values | perineural_invasion stringclasses 3
values | margin_status stringclasses 4
values | ihc_er stringclasses 3
values | ihc_pr stringclasses 3
values | ihc_her2 stringclasses 4
values | ihc_ki67_index stringclasses 825
values | ihc_p53 stringclasses 3
values | molecular_subtype stringclasses 4
values | specimen_type stringclasses 4
values | diagnosis_confirmed stringclasses 3
values | turnaround_time_days int64 3 27 | scenario stringclasses 1
value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
PATH-GHA-2021-00501 | Ghana | 2,021 | Regional | Prostate | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Positive | Positive | Not done | Positive | null | Resection | Yes | 10 | moderate_burden |
PATH-TAN-2018-00502 | Tanzania | 2,018 | Regional | Ovary | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Positive | Negative | 58.0 | Negative | null | Fine needle aspirate | Yes | 24 | moderate_burden |
PATH-GHA-2020-00503 | Ghana | 2,020 | National referral | Prostate | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Negative | Negative | 49.9 | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-TAN-2020-00504 | Tanzania | 2,020 | Regional | Breast | 8510/3 | Medullary carcinoma | Poorly differentiated | Not documented | Absent | Close | Negative | Not done | Not done | Not done | Positive | Triple negative | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-NIG-2021-00505 | Nigeria | 2,021 | Regional | Ovary | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 42.3 | Not done | null | Fine needle aspirate | Yes | 18 | moderate_burden |
PATH-SOU-2021-00506 | South Africa | 2,021 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | 69.2 | Positive | null | Resection | Yes | 9 | moderate_burden |
PATH-KEN-2022-00507 | Kenya | 2,022 | Regional | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Positive | Negative | Negative | Not done | Not done | Positive | null | Resection | Yes | 3 | moderate_burden |
PATH-NIG-2022-00508 | Nigeria | 2,022 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Positive | 61.4 | Negative | null | Resection | Yes | 9 | moderate_burden |
PATH-GHA-2020-00509 | Ghana | 2,020 | District | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Positive | Not done | Not done | Not done | 59.2 | Negative | null | Fine needle aspirate | Yes | 10 | moderate_burden |
PATH-UGA-2025-00510 | Uganda | 2,025 | Regional | Liver | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Positive | Negative | Not done | Positive | null | Fine needle aspirate | Yes | 9 | moderate_burden |
PATH-ETH-2018-00511 | Ethiopia | 2,018 | District | Lung | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Close | Not done | Negative | Negative | 61.9 | Negative | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-TAN-2021-00512 | Tanzania | 2,021 | District | Breast | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Negative | Positive | Negative | Not done | Negative | Luminal A | Excisional biopsy | No - inconclusive | 10 | moderate_burden |
PATH-ETH-2018-00513 | Ethiopia | 2,018 | District | Prostate | 8310/3 | Clear cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Not done | Negative | Not done | Not done | null | Core needle biopsy | No - inconclusive | 15 | moderate_burden |
PATH-GHA-2025-00514 | Ghana | 2,025 | District | Lung | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Not documented | Negative | Positive | Positive | Positive | Not done | Positive | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-NIG-2018-00515 | Nigeria | 2,018 | District | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Close | Negative | Positive | Negative | 76.5 | Negative | Luminal A | Core needle biopsy | Yes | 17 | moderate_burden |
PATH-GHA-2019-00516 | Ghana | 2,019 | District | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 10.0 | Positive | null | Core needle biopsy | No - inconclusive | 5 | moderate_burden |
PATH-SOU-2021-00517 | South Africa | 2,021 | Regional | Breast | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Absent | Not applicable | Positive | Negative | Not done | 57.1 | Not done | null | Resection | Yes | 19 | moderate_burden |
PATH-SOU-2024-00518 | South Africa | 2,024 | National referral | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Not done | Positive | Negative | 75.3 | Positive | null | Core needle biopsy | Yes | 13 | moderate_burden |
PATH-GHA-2023-00519 | Ghana | 2,023 | Regional | Lung | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Positive | Negative | Positive | Negative | 34.9 | Positive | null | Fine needle aspirate | Yes | 25 | moderate_burden |
PATH-KEN-2022-00520 | Kenya | 2,022 | National referral | Colorectal | 8500/3 | Ductal carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Positive | Negative | 40.5 | Negative | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-NIG-2021-00521 | Nigeria | 2,021 | National referral | Breast | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Not applicable | Negative | Positive | Negative | 34.1 | Negative | Luminal B | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-TAN-2019-00522 | Tanzania | 2,019 | District | Lung | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Not documented | Not applicable | Positive | Positive | Negative | 67.3 | Positive | null | Excisional biopsy | Yes | 6 | moderate_burden |
PATH-TAN-2021-00523 | Tanzania | 2,021 | District | Stomach | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Not documented | Not applicable | Not done | Positive | Positive | 37.2 | Negative | null | Excisional biopsy | Yes | 18 | moderate_burden |
PATH-KEN-2018-00524 | Kenya | 2,018 | District | Cervix | 8510/3 | Medullary carcinoma | Poorly differentiated | Present | Not documented | Positive | Positive | Not done | Negative | Not done | Positive | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-UGA-2018-00525 | Uganda | 2,018 | District | Stomach | 8720/3 | Melanoma | Moderately differentiated | Present | Not documented | Negative | Negative | Positive | Positive | Not done | Negative | null | Resection | Yes | 23 | moderate_burden |
PATH-SOU-2021-00526 | South Africa | 2,021 | National referral | Bladder | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Not documented | Negative | Negative | Positive | Negative | 48.3 | Positive | null | Core needle biopsy | No - inconclusive | 25 | moderate_burden |
PATH-TAN-2023-00527 | Tanzania | 2,023 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Close | Negative | Negative | Negative | 50.2 | Positive | null | Resection | Yes | 16 | moderate_burden |
PATH-GHA-2021-00528 | Ghana | 2,021 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Undifferentiated | Absent | Not documented | Negative | Negative | Negative | Positive | Not done | Positive | null | Resection | Yes | 18 | moderate_burden |
PATH-SOU-2023-00529 | South Africa | 2,023 | District | Lung | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | No - inconclusive | 25 | moderate_burden |
PATH-NIG-2019-00530 | Nigeria | 2,019 | District | Prostate | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Close | Positive | Positive | Negative | 55.0 | Negative | null | Core needle biopsy | Yes | 15 | moderate_burden |
PATH-NIG-2025-00531 | Nigeria | 2,025 | Regional | Liver | 8430/3 | Mucoepidermoid carcinoma | Moderately differentiated | Absent | Not documented | Negative | Positive | Negative | Negative | 80.9 | Negative | null | Core needle biopsy | Yes | 4 | moderate_burden |
PATH-ETH-2023-00532 | Ethiopia | 2,023 | District | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Not documented | Negative | Positive | Negative | Negative | 57.8 | Positive | HER2+ | Core needle biopsy | Yes | 18 | moderate_burden |
PATH-SOU-2021-00533 | South Africa | 2,021 | District | Prostate | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Absent | Positive | Not done | Negative | Not done | Not done | Positive | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-SOU-2018-00534 | South Africa | 2,018 | National referral | Liver | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Negative | Positive | Positive | 34.8 | Positive | null | Resection | Yes | 12 | moderate_burden |
PATH-SOU-2022-00535 | South Africa | 2,022 | District | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Negative | Negative | Not done | Not done | null | Excisional biopsy | Yes | 25 | moderate_burden |
PATH-GHA-2025-00536 | Ghana | 2,025 | District | Thyroid | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Not done | Not done | Not done | Positive | null | Core needle biopsy | No - inconclusive | 27 | moderate_burden |
PATH-KEN-2019-00537 | Kenya | 2,019 | District | Ovary | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Positive | Negative | Positive | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 12 | moderate_burden |
PATH-ETH-2019-00538 | Ethiopia | 2,019 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Present | Negative | Negative | Negative | Negative | Not done | Negative | null | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-NIG-2021-00539 | Nigeria | 2,021 | Regional | Thyroid | 8260/3 | Papillary carcinoma | Poorly differentiated | Absent | Present | Negative | Negative | Negative | Negative | Not done | Positive | null | Core needle biopsy | No - suboptimal | 22 | moderate_burden |
PATH-ETH-2025-00540 | Ethiopia | 2,025 | National referral | Thyroid | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Absent | Negative | Positive | Negative | Not done | 66.1 | Negative | null | Core needle biopsy | No - inconclusive | 27 | moderate_burden |
PATH-GHA-2024-00541 | Ghana | 2,024 | Regional | Stomach | 8310/3 | Clear cell carcinoma | Poorly differentiated | Present | Present | Close | Negative | Negative | Positive | Not done | Negative | null | Excisional biopsy | Yes | 6 | moderate_burden |
PATH-UGA-2025-00542 | Uganda | 2,025 | Regional | Colorectal | 8310/3 | Clear cell carcinoma | Poorly differentiated | Not documented | Present | Negative | Negative | Not done | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 8 | moderate_burden |
PATH-GHA-2019-00543 | Ghana | 2,019 | National referral | Ovary | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 26.5 | Positive | null | Fine needle aspirate | No - inconclusive | 12 | moderate_burden |
PATH-UGA-2020-00544 | Uganda | 2,020 | National referral | Lung | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Absent | Negative | Negative | Negative | Negative | 23.6 | Positive | null | Core needle biopsy | Yes | 22 | moderate_burden |
PATH-TAN-2023-00545 | Tanzania | 2,023 | District | Stomach | 8510/3 | Medullary carcinoma | Undifferentiated | Absent | Absent | Positive | Positive | Positive | Positive | 85.0 | Positive | null | Resection | Yes | 27 | moderate_burden |
PATH-KEN-2024-00546 | Kenya | 2,024 | National referral | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Present | Negative | Positive | Negative | Negative | 35.5 | Positive | null | Core needle biopsy | Yes | 27 | moderate_burden |
PATH-NIG-2020-00547 | Nigeria | 2,020 | Regional | Stomach | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Negative | Positive | Negative | Negative | 68.8 | Negative | null | Core needle biopsy | No - suboptimal | 3 | moderate_burden |
PATH-ETH-2022-00548 | Ethiopia | 2,022 | District | Stomach | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 72.1 | Positive | null | Resection | Yes | 4 | moderate_burden |
PATH-GHA-2024-00549 | Ghana | 2,024 | District | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Absent | Not applicable | Not done | Negative | Negative | 28.1 | Positive | Luminal A | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-TAN-2024-00550 | Tanzania | 2,024 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Negative | Not done | Positive | Negative | Not done | Negative | null | Fine needle aspirate | Yes | 9 | moderate_burden |
PATH-NIG-2024-00551 | Nigeria | 2,024 | National referral | Thyroid | 8500/3 | Ductal carcinoma | Moderately differentiated | Not documented | Not documented | Negative | Positive | Negative | Negative | 37.1 | Positive | null | Fine needle aspirate | Yes | 13 | moderate_burden |
PATH-SOU-2019-00552 | South Africa | 2,019 | District | Prostate | 8310/3 | Clear cell carcinoma | Poorly differentiated | Not documented | Present | Negative | Positive | Positive | Negative | Not done | Not done | null | Fine needle aspirate | Yes | 11 | moderate_burden |
PATH-GHA-2022-00553 | Ghana | 2,022 | Regional | Prostate | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Absent | Close | Negative | Positive | Negative | Not done | Positive | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-GHA-2024-00554 | Ghana | 2,024 | Regional | Thyroid | 8500/3 | Ductal carcinoma | Well differentiated | Absent | Not documented | Negative | Not done | Positive | Negative | 51.3 | Not done | null | Excisional biopsy | Yes | 13 | moderate_burden |
PATH-KEN-2025-00555 | Kenya | 2,025 | District | Thyroid | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Not documented | Negative | Negative | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 20 | moderate_burden |
PATH-NIG-2025-00556 | Nigeria | 2,025 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Close | Negative | Not done | Positive | 16.9 | Positive | null | Core needle biopsy | No - inconclusive | 11 | moderate_burden |
PATH-KEN-2020-00557 | Kenya | 2,020 | Regional | Breast | 8260/3 | Papillary carcinoma | Moderately differentiated | Not documented | Absent | Close | Positive | Not done | Negative | 67.6 | Positive | Triple negative | Excisional biopsy | No - inconclusive | 27 | moderate_burden |
PATH-GHA-2020-00558 | Ghana | 2,020 | Regional | Prostate | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Positive | Positive | Positive | Not done | Not done | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-UGA-2023-00559 | Uganda | 2,023 | National referral | Thyroid | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Negative | Not done | Negative | 80.2 | Negative | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-TAN-2022-00560 | Tanzania | 2,022 | District | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Absent | Close | Positive | Positive | Positive | 77.0 | Positive | null | Excisional biopsy | Yes | 24 | moderate_burden |
PATH-TAN-2023-00561 | Tanzania | 2,023 | Regional | Prostate | 8140/3 | Adenocarcinoma | Poorly differentiated | Present | Not documented | Negative | Positive | Positive | Negative | 60.4 | Positive | null | Resection | Yes | 13 | moderate_burden |
PATH-ETH-2022-00562 | Ethiopia | 2,022 | Regional | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Not documented | Not documented | Close | Positive | Positive | Not done | 72.5 | Negative | null | Core needle biopsy | Yes | 8 | moderate_burden |
PATH-UGA-2019-00563 | Uganda | 2,019 | National referral | Breast | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Positive | Not done | Positive | Negative | 56.4 | Negative | Luminal A | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-UGA-2022-00564 | Uganda | 2,022 | Regional | Bladder | 8510/3 | Medullary carcinoma | Poorly differentiated | Not documented | Absent | Negative | Negative | Positive | Negative | 73.1 | Negative | null | Excisional biopsy | Yes | 11 | moderate_burden |
PATH-KEN-2021-00565 | Kenya | 2,021 | District | Breast | 8510/3 | Medullary carcinoma | Poorly differentiated | Present | Not documented | Positive | Positive | Positive | Negative | 22.7 | Negative | Luminal B | Excisional biopsy | Yes | 21 | moderate_burden |
PATH-GHA-2024-00566 | Ghana | 2,024 | District | Cervix | 8500/3 | Ductal carcinoma | Undifferentiated | Present | Not documented | Positive | Positive | Positive | Negative | 67.4 | Negative | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-UGA-2020-00567 | Uganda | 2,020 | Regional | Breast | 8140/3 | Adenocarcinoma | Undifferentiated | Absent | Absent | Positive | Positive | Negative | Negative | 62.3 | Negative | HER2+ | Core needle biopsy | Yes | 3 | moderate_burden |
PATH-UGA-2018-00568 | Uganda | 2,018 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Absent | Not documented | Positive | Not done | Positive | Positive | 33.0 | Negative | null | Core needle biopsy | Yes | 25 | moderate_burden |
PATH-NIG-2018-00569 | Nigeria | 2,018 | District | Cervix | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Absent | Negative | Positive | Negative | Negative | Not done | Positive | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-UGA-2018-00570 | Uganda | 2,018 | District | Thyroid | 8140/3 | Adenocarcinoma | Well differentiated | Absent | Not documented | Negative | Not done | Positive | Positive | Not done | Positive | null | Fine needle aspirate | Yes | 21 | moderate_burden |
PATH-UGA-2022-00571 | Uganda | 2,022 | Regional | Bladder | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | 76.4 | Positive | null | Core needle biopsy | Yes | 16 | moderate_burden |
PATH-NIG-2024-00572 | Nigeria | 2,024 | National referral | Ovary | 8310/3 | Clear cell carcinoma | Poorly differentiated | Present | Absent | Close | Negative | Positive | Negative | 66.9 | Negative | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-NIG-2019-00573 | Nigeria | 2,019 | National referral | Stomach | 8310/3 | Clear cell carcinoma | Undifferentiated | Absent | Present | Positive | Negative | Positive | Negative | 86.4 | Positive | null | Core needle biopsy | Yes | 7 | moderate_burden |
PATH-KEN-2025-00574 | Kenya | 2,025 | Regional | Breast | 8070/3 | Squamous cell carcinoma | Undifferentiated | Present | Not documented | Negative | Positive | Positive | Not done | 69.7 | Positive | Triple negative | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-TAN-2023-00575 | Tanzania | 2,023 | National referral | Cervix | 8510/3 | Medullary carcinoma | Poorly differentiated | Absent | Absent | Positive | Positive | Negative | Negative | 82.7 | Positive | null | Core needle biopsy | Yes | 10 | moderate_burden |
PATH-SOU-2020-00576 | South Africa | 2,020 | Regional | Bladder | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Absent | Negative | Positive | Positive | Negative | Not done | Negative | null | Resection | Yes | 21 | moderate_burden |
PATH-ETH-2025-00577 | Ethiopia | 2,025 | Regional | Bladder | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Absent | Not documented | Close | Positive | Positive | Negative | 39.4 | Negative | null | Core needle biopsy | Yes | 19 | moderate_burden |
PATH-KEN-2020-00578 | Kenya | 2,020 | District | Stomach | 8070/3 | Squamous cell carcinoma | Well differentiated | Not documented | Not documented | Negative | Positive | Positive | Positive | Not done | Positive | null | Resection | Yes | 15 | moderate_burden |
PATH-SOU-2019-00579 | South Africa | 2,019 | District | Prostate | 8140/3 | Adenocarcinoma | Undifferentiated | Not documented | Absent | Negative | Negative | Positive | Negative | Not done | Not done | null | Resection | Yes | 3 | moderate_burden |
PATH-KEN-2024-00580 | Kenya | 2,024 | Regional | Liver | 8500/3 | Ductal carcinoma | Poorly differentiated | Present | Not documented | Close | Negative | Negative | Positive | Not done | Not done | null | Excisional biopsy | Yes | 26 | moderate_burden |
PATH-SOU-2018-00581 | South Africa | 2,018 | Regional | Stomach | 8510/3 | Medullary carcinoma | Well differentiated | Not documented | Absent | Not applicable | Positive | Positive | Positive | 30.5 | Positive | null | Core needle biopsy | Yes | 14 | moderate_burden |
PATH-KEN-2019-00582 | Kenya | 2,019 | National referral | Lung | 8140/3 | Adenocarcinoma | Moderately differentiated | Present | Present | Negative | Positive | Positive | Negative | 42.0 | Positive | null | Core needle biopsy | Yes | 11 | moderate_burden |
PATH-TAN-2023-00583 | Tanzania | 2,023 | Regional | Bladder | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 15.1 | Not done | null | Excisional biopsy | Yes | 15 | moderate_burden |
PATH-GHA-2018-00584 | Ghana | 2,018 | Regional | Thyroid | 8890/3 | Leiomyosarcoma | Poorly differentiated | Present | Absent | Negative | Not done | Not done | Positive | Not done | Positive | null | Core needle biopsy | Yes | 21 | moderate_burden |
PATH-NIG-2019-00585 | Nigeria | 2,019 | Regional | Stomach | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Not documented | Positive | Positive | Negative | Negative | 29.2 | Positive | null | Core needle biopsy | No - inconclusive | 22 | moderate_burden |
PATH-NIG-2023-00586 | Nigeria | 2,023 | Regional | Thyroid | 8140/3 | Adenocarcinoma | Undifferentiated | Present | Absent | Close | Positive | Positive | Negative | Not done | Positive | null | Resection | No - inconclusive | 7 | moderate_burden |
PATH-UGA-2019-00587 | Uganda | 2,019 | Regional | Bladder | 8500/3 | Ductal carcinoma | Undifferentiated | Absent | Present | Negative | Negative | Negative | Positive | 78.4 | Positive | null | Excisional biopsy | Yes | 4 | moderate_burden |
PATH-ETH-2024-00588 | Ethiopia | 2,024 | National referral | Ovary | 8500/3 | Ductal carcinoma | Moderately differentiated | Present | Not documented | Negative | Positive | Negative | Negative | 15.6 | Positive | null | Resection | Yes | 6 | moderate_burden |
PATH-NIG-2024-00589 | Nigeria | 2,024 | National referral | Cervix | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Absent | Present | Negative | Positive | Positive | Negative | 14.2 | Negative | null | Resection | Yes | 17 | moderate_burden |
PATH-ETH-2024-00590 | Ethiopia | 2,024 | District | Ovary | 8140/3 | Adenocarcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Not done | Negative | 47.0 | Positive | null | Excisional biopsy | Yes | 27 | moderate_burden |
PATH-UGA-2023-00591 | Uganda | 2,023 | National referral | Colorectal | 8500/3 | Ductal carcinoma | Moderately differentiated | Absent | Present | Close | Not done | Positive | Negative | 87.6 | Negative | null | Resection | Yes | 20 | moderate_burden |
PATH-NIG-2022-00592 | Nigeria | 2,022 | National referral | Lung | 8510/3 | Medullary carcinoma | Undifferentiated | Present | Absent | Negative | Negative | Negative | Negative | 12.5 | Positive | null | Excisional biopsy | Yes | 8 | moderate_burden |
PATH-KEN-2021-00593 | Kenya | 2,021 | District | Bladder | 8070/3 | Squamous cell carcinoma | Moderately differentiated | Present | Absent | Positive | Positive | Positive | Not done | 43.6 | Positive | null | Fine needle aspirate | Yes | 25 | moderate_burden |
PATH-UGA-2020-00594 | Uganda | 2,020 | Regional | Colorectal | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Absent | Not applicable | Positive | Positive | Negative | 61.2 | Negative | null | Core needle biopsy | No - suboptimal | 6 | moderate_burden |
PATH-SOU-2020-00595 | South Africa | 2,020 | Regional | Thyroid | 8260/3 | Papillary carcinoma | Well differentiated | Absent | Absent | Negative | Negative | Positive | Negative | 81.2 | Positive | null | Excisional biopsy | Yes | 7 | moderate_burden |
PATH-ETH-2020-00596 | Ethiopia | 2,020 | Regional | Liver | 8140/3 | Adenocarcinoma | Poorly differentiated | Absent | Not documented | Negative | Negative | Positive | Negative | 14.3 | Negative | null | Core needle biopsy | Yes | 9 | moderate_burden |
PATH-UGA-2019-00597 | Uganda | 2,019 | District | Thyroid | 8720/3 | Melanoma | Undifferentiated | Present | Present | Negative | Positive | Positive | Positive | Not done | Negative | null | Excisional biopsy | Yes | 5 | moderate_burden |
PATH-TAN-2024-00598 | Tanzania | 2,024 | National referral | Breast | 8070/3 | Squamous cell carcinoma | Poorly differentiated | Not documented | Absent | Negative | Positive | Positive | Negative | 48.7 | Negative | null | Resection | Yes | 10 | moderate_burden |
PATH-GHA-2024-00599 | Ghana | 2,024 | District | Cervix | 8260/3 | Papillary carcinoma | Moderately differentiated | Absent | Not documented | Negative | Negative | Negative | Positive | Not done | Negative | null | Excisional biopsy | Yes | 10 | moderate_burden |
PATH-NIG-2021-00600 | Nigeria | 2,021 | Regional | Colorectal | 8500/3 | Ductal carcinoma | Well differentiated | Present | Present | Close | Positive | Positive | Positive | 49.4 | Positive | null | Excisional biopsy | Yes | 19 | moderate_burden |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.